Literature DB >> 31588427

Vascular disease and type 2 diabetes: the science policy case for early cardiometabolic intervention.

David Taylor.   

Abstract

Entities:  

Year:  2019        PMID: 31588427      PMCID: PMC6738643          DOI: 10.1097/XCE.0000000000000171

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


× No keyword cloud information.
  10 in total

Review 1.  Mendelian randomisation in type 2 diabetes and coronary artery disease.

Authors:  Timothy M Frayling; Charli E Stoneman
Journal:  Curr Opin Genet Dev       Date:  2018-06-20       Impact factor: 5.578

Review 2.  SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.

Authors:  Subodh Verma; John J V McMurray
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

3.  Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.

Authors:  Mark McClellan; Nancy Brown; Robert M Califf; John J Warner
Journal:  Circulation       Date:  2019-02-26       Impact factor: 29.690

4.  Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

Authors:  Michael Ej Lean; Wilma S Leslie; Alison C Barnes; Naomi Brosnahan; George Thom; Louise McCombie; Carl Peters; Sviatlana Zhyzhneuskaya; Ahmad Al-Mrabeh; Kieren G Hollingsworth; Angela M Rodrigues; Lucia Rehackova; Ashley J Adamson; Falko F Sniehotta; John C Mathers; Hazel M Ross; Yvonne McIlvenna; Renae Stefanetti; Michael Trenell; Paul Welsh; Sharon Kean; Ian Ford; Alex McConnachie; Naveed Sattar; Roy Taylor
Journal:  Lancet       Date:  2017-12-05       Impact factor: 79.321

5.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 6.  Historical perspectives on the management of hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

Review 7.  Mendelian randomisation in cardiovascular research: an introduction for clinicians.

Authors:  Derrick A Bennett; Michael V Holmes
Journal:  Heart       Date:  2017-06-08       Impact factor: 5.994

8.  Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study.

Authors:  Clare J Taylor; José M Ordóñez-Mena; Andrea K Roalfe; Sarah Lay-Flurrie; Nicholas R Jones; Tom Marshall; F D Richard Hobbs
Journal:  BMJ       Date:  2019-02-13

9.  Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.

Authors: 
Journal:  Lancet       Date:  2019-02-02       Impact factor: 202.731

Review 10.  Type 2 diabetes: etiology and reversibility.

Authors:  Roy Taylor
Journal:  Diabetes Care       Date:  2013-04       Impact factor: 19.112

  10 in total
  2 in total

1.  Cardiometabolic medicine: time to recognize a new clinical specialty?

Authors:  Andrew J Krentz; Stephan Jacob
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

2.  Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders : A Commentary on: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. A Focus on Early Phase Clinical Drug Development, Second Edition.

Authors:  Amedeo Lonardo; Enrica Baldelli
Journal:  Diabetes Ther       Date:  2020-03-07       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.